Let go of the myth: safety of indocyanine green for sentinel lymph node mapping in endometrial cancer.
Ilaria CapassoGiuseppe CucinellaGerald VolcheckMichaela McGreeAngela J FoughtOlena ChuzhykLuigi Antonio De VitisGabriella SchivardiDiletta FumagalliTommaso OcchialiFrancesco FanfaniVito ChianteraGiovanni ScambiaEvelyn ReynoldsAndrea MarianiGretchen E GlaserPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Indocyanine green injection for sentinel lymph node mapping in patients with endometrial cancer caused no immediate/delayed anaphylactic or other severe allergic reactions. This included patients with a history of other allergies, asthma, and comorbidities. The myth of iodine's relationship to allergic reactions must be refuted to allow indocyanine green use in patients with a history of contrast media or shellfish allergy.
Keyphrases
- endometrial cancer
- sentinel lymph node
- allergic rhinitis
- lymph node
- early stage
- high resolution
- neoadjuvant chemotherapy
- atopic dermatitis
- high density
- chronic obstructive pulmonary disease
- magnetic resonance
- lung function
- early onset
- squamous cell carcinoma
- mass spectrometry
- computed tomography
- contrast enhanced
- dual energy
- locally advanced